Mergers and Acquisitions

Abenza Acquires US CDMO PacificGMP

September 14, 2015

Abenza acquired biopharmaceutical CDMO PacificGMP and expanded the company’s San Diego facility.

Cipla Acquires US Companies InvaGen and Exelan

September 09, 2015

Mumbai-based Cipla agreed to acquire US companies InvaGen and Exelan, giving Cipla US tablet and capsule production capacity, a more diversified portfolio, and market access.

Shire Acquires Foresight Biotherapeutics for $300 Million

August 04, 2015

The acquisition strengthens Shire’s ophthalmics portfolio.

Hikma Acquires Boehringer’s US Generic Drug Business for $2.65 Billion

July 29, 2015

The purchase will strengthen Hikma’s position in the US generic drug market.

Teva Withdraws Mylan Offer, Agrees to Acquire Allergan’s Generics Business

July 27, 2015

The deal to acquire Allergan’s generic-drug business is valued at $40.5 billion.

Allergan Signs Deal with Merck, Acquires Rights to Migraine Development Program

July 07, 2015

The agreement gives Allergan a foothold in migraine drug development.

Allergan Acquires Kythera for $2.1 Billion

June 18, 2015

Kythera announces that it entered into a definitive agreement to be acquired by Allergan for $2.1 billion.

Alexion Acquires Synageva for $8.4 Billion

May 06, 2015

Alexion announces it will expand its rare disease pipeline with a definitive agreement to acquire Synageva.

Teva Proposes $40 Billion to Acquire Mylan

April 21, 2015

Teva announces that it would pay up to $40 billion in cash and stock to acquire Mylan.